Search Results (337)

Cell population and vascular vessel distribution analysis in membrane-based scaffolds for tissue engineering is crucial. Biomimetic nanostructured membranes of methyl methacrylate/hydroxyethyl methacrylate and methyl acrylate/hydroxyethyl acrylate (MMA)1-co-(HEMA)1/(MA)3-co-(HEA)2 loaded with 5% wt SiO2-nanoparticles (Si-M) were doped with zinc (Zn-M) or doxycycline (Dox-M). Critical bone defects were effectuated on six New Zealand-bred rabbit skulls and then they were covered with the membrane-based scaffolds. After six weeks, bone cell population in terms of osteoblasts, osteoclasts, osteocytes, fibroblasts, and M1 and M2 macrophages and vasculature was determined. The areas of interest were the space above (over) and below (under) the membrane, apart from the interior (inner) compartment. All membranes showed that vasculature and most cell types were more abundant under the membrane than in the inner or above regions. Quantitatively, osteoblast density increased by approximately 35% in Zn-M and 25% in Si-M compared with Dox-M. Osteoclast counts decreased by about 78% in Dox-M, indicating strong inhibition of bone resorption. Vascular structures were nearly twofold more frequent under the membranes, particularly in Si-M, while fibroblast presence remained moderate and evenly distributed. The M1/M2 macrophage ratio was higher in Zn-M, reflecting a transient pro-inflammatory state, whereas Dox-M favored an anti-inflammatory, pro-regenerative profile. These results indicate that the biomimetic electrospun membranes functioned as architectural templates that provided favorable microenvironments for cell colonization, angiogenesis, and early bone regeneration in a preclinical in vivo model. Zn-M membranes appear suitable for early osteogenic stimulation, while Dox-M membranes may be advantageous in clinical contexts requiring modulation of inflammation and osteoclastic activity. Full article

Coagulation–flocculation, historically reliant on simple inorganic salts, has evolved into a technically sophisticated process that is central to the removal of turbidity, suspended solids, organic matter, and an expanding array of micropollutants from complex wastewaters. This review synthesizes six decades of research, charting the transition from classical aluminum and iron salts to high-performance polymeric, biosourced, and hybrid coagulants, and examines their comparative efficiency across multiple performance indicators—turbidity removal (>95%), COD/BOD reduction (up to 90%), and heavy metal abatement (>90%). Emphasis is placed on recent innovations, including magnetic composites, bio–mineral hybrids, and functionalized nanostructures, which integrate multiple mechanisms—charge neutralization, sweep flocculation, polymer bridging, and targeted adsorption—within a single formulation. Beyond performance, the review highlights persistent scientific gaps: incomplete understanding of molecular-scale interactions between coagulants and emerging contaminants such as microplastics, per- and polyfluoroalkyl substances (PFAS), and engineered nanoparticles; limited real-time analysis of flocculation kinetics and floc structural evolution; and the absence of predictive, mechanistically grounded models linking influent chemistry, coagulant properties, and operational parameters. Addressing these knowledge gaps is essential for transitioning from empirical dosing strategies to fully optimized, data-driven control. The integration of advanced coagulation into modular treatment trains, coupled with IoT-enabled sensors, zeta potential monitoring, and AI-based control algorithms, offers the potential to create “Coagulation 4.0” systems—adaptive, efficient, and embedded within circular economy frameworks. In this paradigm, treatment objectives extend beyond regulatory compliance to include resource recovery from coagulation sludge (nutrients, rare metals, construction materials) and substantial reductions in chemical and energy footprints. By uniting advances in material science, process engineering, and real-time control, coagulation–flocculation can retain its central role in water treatment while redefining its contribution to sustainability. In the systems envisioned here, every floc becomes both a vehicle for contaminant removal and a functional carrier in the broader water–energy–resource nexus. Full article

Melanin-based biosorbents (MiCS), derived from chestnut shells, were encapsulated in sodium alginate to obtain MiCS@Alg, useful in a column adsorption study. MiCS contains various acidic surface groups able to participate in the removal of cationic pollutants from aqueous solutions. The MiCS and MiCS@Alg were characterized by Fourier-transform Infrared Spectroscopy (FTIR), Scanning Electron Microscopy (SEM), and Dynamic Light Scattering (DLS), while zeta potential and particle size analyses were performed to gain deeper insight into surface charge behavior. Batch adsorption experiments were carried out at three different temperatures, demonstrating that the adsorption kinetics followed a pseudo-second-order (PSO) model and that the Freundlich model best described the equilibrium data. The process was found to be endothermic and spontaneous, with maximum adsorption capacities of 300.2 mg g⁻¹ (BR2), 201.5 mg g⁻¹ (BY28) and 73.08 mg g⁻¹ (NH₃) on MiCS, and 189.3 mg g⁻¹ (BR2), 117.1 mg g⁻¹ (BY28) and 50.06 mg g⁻¹ (NH₃) on MiCS@Alg at 45 °C and compared with the unmodified chestnut shell. The MiCS and MiCS@Alg exhibited good adsorption performance, improved environmental compatibility, and greater reusability. Overall, these results highlight MiCS@Alg as a cost-effective, sustainable, and highly promising novel biosorbent for the removal of cationic pollutants (BR2, BY28, and NH₃) from water. Full article

A key obstacle to the efficacy of cancer drugs is the safe delivery of the drugs to the target site of the disease. Recent advances in nanomedicine have introduced smart hydrogel nanoparticles as promising, efficient, secure, and stimulus-responsive drug carriers. Herein, a bio-safe pH-sensitive nanohydrogel (NG) made of polyaminoethyl methacrylamide (AEMA)-grafted dextran was used as a carrier for liver-targeted doxorubicin (DOX) delivery. Lactobionate (SL) residue was conjugated to the prepared NG as a targeting agent, and DOX was also conjugated via Schiff base linkage. The synthesized structure was analyzed using ¹HNMR, FT-IR, and size exclusion chromatography. DOX release was confirmed through UV-Vis spectroscopy. A pH-responsive manner in the DOX release profile was observed in a simulated medium with pH changes. In vitro toxicity assessment was performed in HepG2 and L929 cell lines, which have demonstrated the biosafety of the prepared hydrogel and its high effectiveness as an anticancer drug delivery system. Full article

Polymeric vesicles, characterized by enhanced colloidal stability, excellent mechanical properties, controllable surface functionality, and adjustable membrane thickness, are extremely useful in nano- and bio-technology for potential applications as nanosized carriers for drugs and enzymes. However, a few preparative steps are necessary to achieve a unilamellar vesicle with a narrow size distribution. Herein, we report the spontaneous formation of unilamellar polymeric vesicles with nanometer sizes (<50 nm), fabricated by simply mixing diblock copolymers (P(EO-AGE)(2K-2K) and P(EO-AGE)(0.75K-2K)) with differing hydrophilic mass fractions in aqueous solutions. Depending on the mixing ratio of block copolymers and the temperature, the block copolymer mixtures self-assemble into various nanostructures, such as spherical and cylindrical micelles, or vesicles. The self-assembled structures of the block copolymer mixtures were characterized by small-angle neutron scattering, resulting in a phase diagram drawn as a function of temperature and the mixing condition. Notably, the critical temperature for the micelle-to-vesicle phase transition can be easily controlled by altering the mixing conditions; it decreases with an increase in the concentration of one of the block copolymers. Full article

Microbial electrosynthesis (MES) has emerged as a promising bio-electrochemical technology for sustainable CO₂ conversion into valuable organic compounds since it uses living electroactive microbes to directly convert CO₂ into value-added products. This review synthesizes advancements in MES from 2010 to 2025, focusing on the electrode materials, microbial communities, reactor engineering, performance trends, techno-economic evaluations, and future challenges, especially on the results reported between 2020 and 2025, thus highlighting that MES technology is now a technology to be reckoned with in the spectrum of biofuel technology production. While the current productivity and scalability of microbial electrochemical systems (MESs) remain limited compared to conventional CO₂ conversion technologies, MES offers distinct advantages, including process simplicity, as it operates under ambient conditions without the need for high pressures or temperatures; modularity, allowing reactors to be stacked or scaled incrementally to match varying throughput requirements; and seamless integration with circular economy strategies, enabling the direct valorization of waste streams, wastewater, or renewable electricity into valuable multi-carbon products. These features position MES as a promising platform for sustainable and adaptable CO₂ utilization, particularly in decentralized or resource-constrained settings. Recent innovations in electrode materials, such as conductive polymers and metal–organic frameworks, have enhanced electron transfer efficiency and microbial attachment, leading to improved MES performance. The development of diverse microbial consortia has expanded the range of products achievable through MES, with studies highlighting the importance of microbial interactions and metabolic pathways in product formation. Advancements in reactor design, including continuous-flow systems and membrane-less configurations, have addressed scalability issues, enhancing mass transfer and system stability. Performance metrics, such as the current densities and product yields, have improved due to exceptionally high product selectivity and surface-area-normalized production compared to abiotic systems, demonstrating the potential of MES for industrial applications. Techno-economic analyses indicate that while MES offers promising economic prospects, challenges related to cost-effective electrode materials and system integration remain. Future research should focus on optimizing microbial communities, developing advanced electrode materials, and designing scalable reactors to overcome the existing limitations. Addressing these challenges will be crucial for the commercialization of MES as a viable technology for sustainable chemical production. Microbial electrosynthesis (MES) offers a novel route to biofuels by directly converting CO₂ and renewable electricity into energy carriers, bypassing the costly biomass feedstocks required in conventional pathways. With advances in electrode materials, reactor engineering, and microbial performance, MES could achieve cost-competitive, carbon-neutral fuels, positioning it as a critical complement to future biofuel technologies. Full article

Fungal mycelial pellets (MPs) exhibit high biomass-loading capacity; however, their application in wastewater treatment is constrained by structural fragility and the risk of environmental dispersion. To overcome these limitations, a dual-crosslinked polyvinyl alcohol–alginate gel (10% PVA, 2% sodium alginate) embedding strategy was developed and stabilized using 2% CaCl₂ and saturated boric acid. This encapsulation enhanced the tensile strength of MPs by 499% (310.4 vs. 62.1 kPa) and improved their settling velocity by 2.3-fold (1.12 vs. 0.49 cm/s), which was critical for stability under turbulent bioreactor conditions. Following encapsulation, the specific oxygen uptake rates (SOURs) of three fungal strains (F557, Y3, and F507) decreased by 30.3%, 54.8%, and 48.3%, respectively, while maintaining metabolic functionality. SEM revealed tight adhesion between the gel layer and both surface and internal hyphae, with the preservation of porous channels conducive to microbial colonization. In sequential-batch reactors treating sulfamethoxazole (SMX)-contaminated wastewater, gel-encapsulated MPs combined with acclimated sludge consistently achieved 72–75% SMX removal efficiency over six cycles, outperforming uncoated MPs (efficiency decreased from 81.2% to 58.7%) and pure gel–sludge composites (34–39%). The gel coating inhibited hyphal dispersion by over 90% and resisted mechanical disintegration under 24 h agitation. This approach offers a scalable and environmentally sustainable means of enhancing MPs’ operational stability in continuous-flow systems while mitigating fungal dissemination risks. Full article

Polymers have long been central to modern materials science, but their durability has also made them major contributors to environmental pollution. A new generation of bio-based and nanostructured polymers is now reshaping this field, offering materials that are functional, reversible, and sustainable. This review examines their role across three interconnected domains: cultural heritage conservation, the protection of medicinal and aromatic plants (MAPs), and environmental sustainability. In heritage science, polymers are moving away from synthetic resins toward renewable systems such as chitosan, nanocellulose, and PLA, which provide stability while remaining reversible and compatible with delicate substrates. In agriculture, biodegradable coatings, controlled-release carriers, and edible films are improving MAP protection, extending shelf life, and reducing reliance on synthetic pesticides. In environmental applications, polymers are being reinvented as solutions rather than problems—through degradable mulches, functional hydrogels, and nanocomposites that clean soils and waters within a circular economy framework. Looking across these domains reveals strong synergies. The same principles—biodegradability, multifunctionality, and responsiveness—apply in each context, turning polymers from passive barriers into intelligent, adaptive systems. Their future success will depend not only on chemistry but also on life-cycle design, policy alignment, and public trust, making polymers key enablers of sustainability. Full article

Lung cancer remains a leading cause of cancer-related mortality worldwide, requiring the development of innovative and effective therapeutic strategies. Bio-functional nanomaterials, due to their unique physicochemical properties, offer a versatile platform for targeted drug delivery, controlled release, and multimodal therapies, thereby enhancing efficacy and reducing the systemic toxicity of conventional treatments. Independently, both vitamin D and vitamin K have demonstrated significant anti-cancer properties, including inhibition of proliferation, induction of apoptosis, modulation of angiogenesis, and attenuation of metastatic potential in various cancer cell lines and in vivo models. However, their clinical application is often limited by poor bioavailability, rapid metabolism, and potential for off-target effects. Specifically, by enhancing the solubility, stability, and targeted accumulation of fat-soluble vitamins D and K within tumoral tissues for improved lung cancer therapy, this review emphasizes the novel and cooperative role of bio-functional nanomaterials in overcoming these limitations. Future studies should focus on the logical development of sophisticated nanomaterial carriers for optimal co-delivery plans and thorough in vivo validation, aiming to convert these encouraging preclinical results into successful clinical treatments for patients with lung cancer. Full article

When iron oxide nanoparticles are incubated together with a biological broth, the biomolecules compete for the binding sites at the solid–liquid interface. At the same time, the biomass rearranges in suspension, building agglomerated structures. Despite general knowledge of the forces involved in bio–nano interactions, gaps remain in the understanding of how biomolecules organize themselves in solution and onto surfaces. This work examines biomolecule adsorption onto metal oxide surfaces with the goal of strengthening this understanding, essential in industrial and natural processes. We demonstrate nearly complete separation of proteins from a biotechnological suspension for non-oxidized and highly oxidized magnetic nanoparticles. Varying the nanoparticle-to-biomass ratio, we find, can lead to different separation patterns, i.e., that selectivity using bare, low-cost materials is possible. Furthermore, we explore how preliminary “passivation” with a biological corona only partially reduces the ability to separate total protein mass from a new suspension in subsequent incubation steps. The study underscores the crucial role of concentration gradients with regard to targets and binding sites as the primary determinant of separation capacity and of biomolecule behavior in solution, highlighting the potential for using bio–nano coronae as biomolecule carriers across diverse fields, including environmental, biomedical, pharmaceutical and nutritional applications. Full article

Background/Objectives: Bio-produced gold nanoparticles (AuNPs) are effective carriers of short RNAs into specialized mammalian cells. Their potential application is still limited by scarce knowledge on their uptake and intracellular fate. Gold nanoparticles that are not biologically produced (NB-AuNPs) enter specialized cells primarily via clathrin-dependent endocytosis. Unlike the NB-AuNPs, the bio AuNPs possess natural surface coatings that significantly alter the AuNPs properties. Our research aimed to reveal the cellular uptake of the AuNPs with respect to delivering a functional RNA cargo. Methods: The AuNPs were conjugated with short inhibitory RNA specific to miR 135b. Mammary cancer cells 4T1 were pretreated with inhibitors of caveolin- and clathrin-mediated endocytosis and macropinocytosis. AuNPs’ uptake, fate, and miR 135b knock-down were assessed with TEM and qPCR. Results: The AuNPs-antimiR 135b conjugates entered 4T1 cells via all the tested pathways and could be seen inside the cells in early and late endosomes as well as cytoplasm. In contrast to the clathrin-dependent pathway, the caveolae-mediated endocytosis and the macropinocytosis of the AuNPs resulted in the effective targeting and reduction of the miR 135b. Conclusions: The bio-produced AuNPs can effectively enter mammalian cells simultaneously by different endocytic pathways but the delivery of functional cargo is not achieved via the clathrin-dependent endocytosis. Full article

Graphene, a two-dimensional carbon material with a hexagonal lattice structure, possesses remarkable properties. Exceptional electrical conductivity, mechanical strength, and high surface area that make it a powerful platform for biosensing applications. Its sp²-hybridised network facilitates efficient electron mobility and enables diverse surface functionalisation through bio-interfacing. This review highlights the core detection mechanisms in graphene-based biosensors. Optical sensing techniques, such as surface plasmon resonance (SPR) and surface-enhanced Raman scattering (SERS), benefit significantly from graphene’s strong light–matter interaction, which enhances signal sensitivity. Although graphene itself lacks intrinsic piezoelectricity, its integration with piezoelectric substrates can augment the performance of piezoelectric biosensors. In electrochemical sensing, graphene-based electrodes support rapid electron transfer, enabling fast response times across a range of techniques, including impedance spectroscopy, amperometry, and voltammetry. Graphene field-effect transistors (GFETs), which leverage graphene’s high carrier mobility, offer real-time, label-free, and highly sensitive detection of biomolecules. In addition, the review also explores multiplexed detection strategies vital for point-of-care diagnostics. Graphene’s nanoscale dimensions and tunable surface chemistry facilitate both array-based configurations and the simultaneous detection of multiple biomarkers. This adaptability makes graphene an ideal material for compact, scalable, and accurate biosensor platforms. Continued advancements in graphene biofunctionalisation, sensing modalities, and integrated multiplexing are driving the development of next-generation biosensors with superior sensitivity, selectivity, and diagnostic reliability. Full article

Background/Objectives: The HLA-B*58:01 allele is strongly linked to severe cutaneous adverse reactions (SCARs) during allopurinol treatment, and it has been associated with the A allele of PSORS1C1 rs9263726 (G>A). Paraclinical characteristics of gout are indicative of associated comorbid conditions. This study investigated the genotype frequency of HLA-B*58:01 and its association with paraclinical characteristics and PSORS1C1 rs9263726 in gout patients from Northeast Vietnam. Methods: A total of 133 unrelated gout patients were randomly recruited by the clinician. BioEdit sequence alignment editor version 7.2.5 software (Raleigh, Raleigh, NC, USA) was used for the analysis of nucleotide sequence data of HLA-B gene alleles from the IPD-IMGT/HLA Database, which showed that the HLA-B*58:01 allele can be distinguished from reference and other alleles by specific nucleotide positions: 387C, 379C, 368A, 355A, and 353T (in exon 3); and 319C, 285G, and 209A (in exon 2). HLA-B*58:01 and PSORS1C1 rs9263726 genotypes were identified using Sanger sequencing of PCR products, analyzed with BioEdit software, and verified using the NCBI dbVar database. Statistical analyses were performed using SPSS version 25.0. Results: Our study revealed a significant age difference between male and female gout patients (p < 0.001). Male gout patients had an average age of 51.44 ± 14.59 years, whereas female gout patients were notably older, with an average age of 70.33 ± 10.64 years. Positive correlations were observed between platelet count, serum creatinine, and uric acid levels (r = 0.174, p = 0.045; r = 0.195, p = 0.025) in male gout patients, while only high-density lipoprotein cholesterol showed a statistically significant negative correlation with uric acid levels (r = −0.885, p = 0.002) in female patients. The HLA-B*58:01 allele frequency among study subjects was 6.02%, with 12.03% being heterozygous individuals (*X/HLA-B*58:01, N = 16). The HLA-B*58:01 allele was not detected in female gout patients. White blood cell counts were significantly higher in male gout patients with the *X/HLA-B*58:01 genotype compared to those with the *X/*X genotype (p = 0.018). The A allele frequency of PSORS1C1 rs9263726 was 7.89%, and the heterozygous mutant genotype PSORS1C1 GA had a frequency of 15.79% (N = 21). Among the *X/*58:01 carriers, 4.51% had the GG genotype, and 7.52% had the GA genotype at PSORS1C1 rs9263726. Conclusions: Our study showed that the HLA-B*58:01 allele was not detected in female gout patients. White blood cell counts differed significantly between the *X/HLA-B*58:01 and *X/*X groups in male gout patients. The A allele of PSORS1C1 rs9263726 was not consistently associated with HLA-B*58:01 and was not a reliable marker for its detection in this study population. Full article

The instability of many volatile organic compounds (VOCs) limits their usage in different fragrance carriers and products. In scratch-and-sniff applications, VOCs are bound so strongly that release cannot happen without an external trigger. On the other hand, other fixatives like cyclodextrins release unstable volatile molecules too rapidly. We engineered biodegradable gelatin films whose release profile can be tuned by glycerol plasticization and alkaline protease degradation. Digitalized VOC release profiles acquired with the described near-real-time analysis toolkit are digital twins that replicate the behavior of the evaluated films in silico. Seven formulations were cast from 10% gelatin containing D-limonene, glycerol (5%, 20%), protease-C 30 kU mL⁻¹, and samples with additional water to establish a higher hydromodule for protease catalytic activity. Release profiles were monitored for nine days at 23 ± 2 °C in parallel by metal-oxide semiconductor (MOS) e-noses, gravimetric weight loss, and near-infrared measurements (NIR). These continuous measurements were cross-checked with gel electrophoresis, FTIR spectroscopy, hardness tests, and sensory intensity ratings. Results showed acceleration of VOC release by enzymatic treatment during the first days, as well as overall impact on the release profile. Differences in low and high glycerol films were observed, and principal component analysis of NIR spectra separated low and high glycerol groups, mirroring the MOS and FTIR data. Usability of MOS data was explored in comparison to more biased and subjective intensity results from sensory panel evaluation. Overall, the created toolkit showed good cross-checked results and enabled the possibility for close to real-time analysis for bio-based VOC carriers. Full article

We report herein the development of a polyclonal antibody against ochratoxin A (OTA) using a specially designed synthetic OTA derivative as the immunizing hapten. This OTA derivative contains a tetrapeptide linker (glycyl-glycyl-glycyl-lysine, GGGK), through which it can be linked to a carrier protein and form an immunogenic conjugate. The OTA derivative (OTA-glycyl-glycyl-glycyl-lysine, OTA-GGGK) has been synthesized on a commercially available resin via the well-established Fmoc-based solid-phase peptide synthesis (Fmoc-SPPS) strategy; overall, this approach has allowed us to avoid tedious liquid-phase synthesis protocols, which are often characterized by multiple steps, several intermediate products and low overall yield. Subsequently, OTA-GGGK was conjugated to bovine thyroglobulin through glutaraldehyde, and the conjugate was used in an immunization protocol. The antiserum obtained was evaluated with a simple-format ELISA in terms of its titer and capability of recognizing the natural free hapten; the anti-OTA antibody, as a whole IgG fragment, was successfully applied to three different immunoanalytical systems for determining OTA in various food materials and wine samples, i.e., a multi-mycotoxin microarray bio-platform, an optical immunosensor, and a biotin–streptavidin ELISA, which has proved the analytical effectiveness and versatility of the anti-OTA antibody developed. The same approach may be followed for developing antibodies against other low-molecular-weight toxins and hazardous substances. Full article